Anis Karimpour-Fard
Concepts (370)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 11 | 2024 | 692 | 1.130 |
Why?
| | Computational Biology | 9 | 2015 | 644 | 0.900 |
Why?
| | Cardiomyopathy, Dilated | 7 | 2025 | 385 | 0.860 |
Why?
| | Protein Interaction Mapping | 3 | 2008 | 109 | 0.610 |
Why?
| | Ventricular Remodeling | 4 | 2025 | 266 | 0.590 |
Why?
| | Software | 2 | 2015 | 665 | 0.570 |
Why?
| | Circulating MicroRNA | 3 | 2023 | 24 | 0.500 |
Why?
| | DNA Copy Number Variations | 2 | 2018 | 182 | 0.450 |
Why?
| | Hibernation | 5 | 2014 | 75 | 0.450 |
Why?
| | Proteomics | 6 | 2015 | 1111 | 0.440 |
Why?
| | Phylogeny | 4 | 2014 | 904 | 0.400 |
Why?
| | Comparative Genomic Hybridization | 2 | 2018 | 30 | 0.380 |
Why?
| | Myocytes, Cardiac | 4 | 2021 | 526 | 0.370 |
Why?
| | Gene Expression Profiling | 10 | 2021 | 1774 | 0.370 |
Why?
| | Sciuridae | 5 | 2014 | 147 | 0.360 |
Why?
| | Escherichia coli | 6 | 2012 | 815 | 0.360 |
Why?
| | Multigene Family | 3 | 2008 | 198 | 0.310 |
Why?
| | Cluster Analysis | 6 | 2021 | 499 | 0.310 |
Why?
| | Biomarkers | 7 | 2024 | 4149 | 0.300 |
Why?
| | Proteome | 3 | 2023 | 472 | 0.300 |
Why?
| | MAP Kinase Kinase Kinases | 2 | 2021 | 73 | 0.280 |
Why?
| | Sequence Analysis, Protein | 1 | 2007 | 30 | 0.280 |
Why?
| | Seasons | 5 | 2014 | 547 | 0.280 |
Why?
| | Ventricular Function, Left | 2 | 2025 | 534 | 0.270 |
Why?
| | Data Collection | 1 | 2010 | 673 | 0.270 |
Why?
| | Gammaproteobacteria | 1 | 2007 | 13 | 0.270 |
Why?
| | Superoxide Dismutase | 2 | 2020 | 346 | 0.260 |
Why?
| | DNA Helicases | 2 | 2021 | 145 | 0.260 |
Why?
| | Metabolic Networks and Pathways | 5 | 2017 | 180 | 0.260 |
Why?
| | Oligonucleotide Array Sequence Analysis | 7 | 2012 | 767 | 0.250 |
Why?
| | Algorithms | 3 | 2008 | 1704 | 0.250 |
Why?
| | Bacterial Proteins | 2 | 2010 | 879 | 0.240 |
Why?
| | Genome, Bacterial | 4 | 2012 | 142 | 0.240 |
Why?
| | Signal Transduction | 4 | 2023 | 5079 | 0.240 |
Why?
| | Genome | 4 | 2014 | 300 | 0.230 |
Why?
| | Amniotic Fluid | 2 | 2024 | 96 | 0.230 |
Why?
| | Escherichia coli Proteins | 3 | 2012 | 200 | 0.220 |
Why?
| | Models, Biological | 2 | 2008 | 1783 | 0.210 |
Why?
| | Arousal | 3 | 2012 | 155 | 0.200 |
Why?
| | Caloric Restriction | 1 | 2024 | 124 | 0.190 |
Why?
| | Fetal Blood | 1 | 2024 | 327 | 0.190 |
Why?
| | Heart Failure | 3 | 2023 | 2236 | 0.190 |
Why?
| | Transcriptome | 4 | 2021 | 971 | 0.190 |
Why?
| | Perforator Flap | 1 | 2022 | 31 | 0.190 |
Why?
| | Heart Defects, Congenital | 2 | 2021 | 842 | 0.190 |
Why?
| | DNA-Binding Proteins | 3 | 2021 | 1502 | 0.190 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2024 | 201 | 0.190 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2023 | 142 | 0.180 |
Why?
| | Species Specificity | 6 | 2008 | 585 | 0.180 |
Why?
| | Bleomycin | 2 | 2020 | 248 | 0.180 |
Why?
| | Focal Adhesions | 1 | 2021 | 44 | 0.180 |
Why?
| | Hypotension | 1 | 2022 | 122 | 0.180 |
Why?
| | Fetofetal Transfusion | 1 | 2021 | 26 | 0.180 |
Why?
| | Heart Rate | 1 | 2025 | 822 | 0.170 |
Why?
| | Milrinone | 1 | 2021 | 29 | 0.170 |
Why?
| | Genetic Variation | 4 | 2018 | 991 | 0.170 |
Why?
| | Prostatic Neoplasms | 2 | 2021 | 1043 | 0.170 |
Why?
| | Mammaplasty | 1 | 2022 | 105 | 0.170 |
Why?
| | Phosphorylation | 3 | 2021 | 1759 | 0.170 |
Why?
| | Biological Products | 1 | 2023 | 216 | 0.160 |
Why?
| | Heart Transplantation | 2 | 2018 | 754 | 0.160 |
Why?
| | Evolution, Molecular | 4 | 2014 | 493 | 0.160 |
Why?
| | Calcium-Binding Proteins | 1 | 2021 | 218 | 0.160 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2025 | 323 | 0.160 |
Why?
| | Receptors, Androgen | 1 | 2021 | 150 | 0.160 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 91 | 0.160 |
Why?
| | RNA Interference | 1 | 2021 | 469 | 0.150 |
Why?
| | Keloid | 1 | 2019 | 7 | 0.150 |
Why?
| | Animals | 24 | 2024 | 36940 | 0.150 |
Why?
| | Myocardium | 2 | 2017 | 1002 | 0.150 |
Why?
| | Dermis | 1 | 2019 | 33 | 0.150 |
Why?
| | RNA, Messenger | 6 | 2024 | 2833 | 0.150 |
Why?
| | Fever | 1 | 2020 | 306 | 0.150 |
Why?
| | Chromatography, Liquid | 3 | 2016 | 433 | 0.150 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2018 | 22 | 0.150 |
Why?
| | Humans | 35 | 2025 | 137585 | 0.140 |
Why?
| | Mosaicism | 1 | 2018 | 73 | 0.140 |
Why?
| | Inflammation | 2 | 2020 | 2837 | 0.140 |
Why?
| | Gene Expression Regulation | 5 | 2018 | 2607 | 0.140 |
Why?
| | Fluorouracil | 1 | 2019 | 208 | 0.140 |
Why?
| | Serum | 1 | 2018 | 59 | 0.140 |
Why?
| | Cardiomyopathies | 1 | 2021 | 350 | 0.140 |
Why?
| | Extracellular Matrix | 1 | 2021 | 528 | 0.140 |
Why?
| | Ovarian Neoplasms | 1 | 2023 | 565 | 0.130 |
Why?
| | Heart Ventricles | 2 | 2021 | 788 | 0.130 |
Why?
| | Databases, Genetic | 2 | 2015 | 237 | 0.130 |
Why?
| | Acute Lung Injury | 1 | 2020 | 287 | 0.130 |
Why?
| | Muscle Proteins | 2 | 2025 | 231 | 0.130 |
Why?
| | Specimen Handling | 1 | 2018 | 183 | 0.130 |
Why?
| | Reference Values | 2 | 2008 | 816 | 0.130 |
Why?
| | Plasma | 1 | 2018 | 212 | 0.120 |
Why?
| | Ventricular Function, Right | 1 | 2018 | 285 | 0.120 |
Why?
| | Models, Genetic | 3 | 2008 | 600 | 0.120 |
Why?
| | Real-Time Polymerase Chain Reaction | 5 | 2017 | 346 | 0.120 |
Why?
| | Tandem Mass Spectrometry | 2 | 2016 | 532 | 0.120 |
Why?
| | Female | 23 | 2025 | 73304 | 0.120 |
Why?
| | Energy Metabolism | 3 | 2023 | 922 | 0.120 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2018 | 545 | 0.120 |
Why?
| | Ethanol | 2 | 2012 | 608 | 0.120 |
Why?
| | Calcium | 1 | 2021 | 1199 | 0.120 |
Why?
| | Hylobates | 1 | 2014 | 8 | 0.110 |
Why?
| | Karyotype | 1 | 2014 | 18 | 0.110 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2020 | 2189 | 0.110 |
Why?
| | Fetus | 1 | 2018 | 806 | 0.110 |
Why?
| | Down-Regulation | 2 | 2021 | 657 | 0.110 |
Why?
| | Case-Control Studies | 4 | 2024 | 3556 | 0.100 |
Why?
| | Phenotype | 3 | 2025 | 3196 | 0.100 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2014 | 121 | 0.100 |
Why?
| | Heart | 2 | 2021 | 655 | 0.100 |
Why?
| | Metabolomics | 2 | 2016 | 678 | 0.100 |
Why?
| | Lymphoma, T-Cell | 1 | 2012 | 25 | 0.100 |
Why?
| | Amino Acids | 1 | 2016 | 497 | 0.100 |
Why?
| | Lipectomy | 1 | 2012 | 7 | 0.100 |
Why?
| | Mutation | 5 | 2023 | 3958 | 0.100 |
Why?
| | Drug Tolerance | 1 | 2012 | 105 | 0.100 |
Why?
| | Fasting | 1 | 2014 | 281 | 0.090 |
Why?
| | Mice | 9 | 2024 | 17787 | 0.090 |
Why?
| | Dog Diseases | 1 | 2012 | 64 | 0.090 |
Why?
| | Subcutaneous Fat | 1 | 2012 | 81 | 0.090 |
Why?
| | Coronary Artery Disease | 1 | 2018 | 698 | 0.090 |
Why?
| | Biomarkers, Tumor | 2 | 2023 | 1276 | 0.090 |
Why?
| | Lymphoma, B-Cell | 1 | 2012 | 106 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 166 | 0.090 |
Why?
| | Abdomen | 1 | 2012 | 125 | 0.090 |
Why?
| | Receptors, Adrenergic, beta-1 | 1 | 2011 | 46 | 0.090 |
Why?
| | Gluconeogenesis | 1 | 2011 | 79 | 0.090 |
Why?
| | Gene Duplication | 3 | 2007 | 68 | 0.090 |
Why?
| | Breast Neoplasms | 2 | 2022 | 2253 | 0.090 |
Why?
| | Male | 17 | 2025 | 67762 | 0.090 |
Why?
| | Recovery of Function | 1 | 2015 | 653 | 0.090 |
Why?
| | Reproducibility of Results | 4 | 2018 | 3284 | 0.080 |
Why?
| | Gene Dosage | 2 | 2010 | 140 | 0.080 |
Why?
| | Bacterial Infections | 1 | 2012 | 250 | 0.080 |
Why?
| | Ligases | 1 | 2010 | 32 | 0.080 |
Why?
| | Sigma Factor | 1 | 2010 | 40 | 0.080 |
Why?
| | Blood Proteins | 1 | 2012 | 252 | 0.080 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2016 | 900 | 0.080 |
Why?
| | Markov Chains | 1 | 2010 | 126 | 0.080 |
Why?
| | Pancreas | 1 | 2012 | 329 | 0.080 |
Why?
| | Glycolysis | 1 | 2011 | 321 | 0.080 |
Why?
| | Gene Regulatory Networks | 2 | 2023 | 305 | 0.080 |
Why?
| | Pregnancy | 4 | 2024 | 6763 | 0.080 |
Why?
| | Child | 8 | 2022 | 21935 | 0.080 |
Why?
| | Oligonucleotides | 1 | 2010 | 148 | 0.080 |
Why?
| | Recombination, Genetic | 1 | 2010 | 204 | 0.080 |
Why?
| | Prospective Studies | 4 | 2024 | 7604 | 0.080 |
Why?
| | Adenosine Triphosphate | 1 | 2011 | 491 | 0.080 |
Why?
| | Escherichia coli K12 | 1 | 2008 | 7 | 0.070 |
Why?
| | Genetic Enhancement | 1 | 2008 | 5 | 0.070 |
Why?
| | Mice, Transgenic | 3 | 2023 | 2167 | 0.070 |
Why?
| | Polymorphism, Genetic | 1 | 2011 | 660 | 0.070 |
Why?
| | DNA Repair | 1 | 2010 | 231 | 0.070 |
Why?
| | Stroke Volume | 2 | 2025 | 612 | 0.070 |
Why?
| | Cell Line, Tumor | 3 | 2023 | 3412 | 0.070 |
Why?
| | Biostatistics | 1 | 2008 | 18 | 0.070 |
Why?
| | Animals, Newborn | 2 | 2021 | 844 | 0.070 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2012 | 860 | 0.070 |
Why?
| | Protein Engineering | 1 | 2008 | 97 | 0.070 |
Why?
| | Computer Simulation | 2 | 2008 | 978 | 0.070 |
Why?
| | Adiposity | 1 | 2012 | 518 | 0.070 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 385 | 0.070 |
Why?
| | Chromosome Mapping | 1 | 2008 | 523 | 0.070 |
Why?
| | Genomics | 1 | 2012 | 795 | 0.070 |
Why?
| | Shigella flexneri | 1 | 2007 | 15 | 0.070 |
Why?
| | Pneumonia | 1 | 2012 | 639 | 0.070 |
Why?
| | Databases, Protein | 1 | 2007 | 85 | 0.060 |
Why?
| | Macaca mulatta | 1 | 2007 | 166 | 0.060 |
Why?
| | Likelihood Functions | 1 | 2007 | 144 | 0.060 |
Why?
| | Primates | 1 | 2007 | 126 | 0.060 |
Why?
| | DNA Probes | 1 | 2006 | 60 | 0.060 |
Why?
| | Models, Statistical | 2 | 2008 | 669 | 0.060 |
Why?
| | Forecasting | 1 | 2007 | 389 | 0.060 |
Why?
| | Liver | 1 | 2014 | 1943 | 0.060 |
Why?
| | Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2025 | 36 | 0.060 |
Why?
| | Genome, Human | 1 | 2007 | 425 | 0.060 |
Why?
| | Cells, Cultured | 3 | 2018 | 4193 | 0.060 |
Why?
| | Sequence Analysis, DNA | 4 | 2010 | 812 | 0.050 |
Why?
| | Kidney | 1 | 2012 | 1468 | 0.050 |
Why?
| | Pregnancy Trimester, Third | 1 | 2024 | 114 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2021 | 2486 | 0.050 |
Why?
| | Potassium Channels | 1 | 2025 | 151 | 0.050 |
Why?
| | Biopsy | 2 | 2019 | 1129 | 0.050 |
Why?
| | Biofilms | 1 | 2007 | 260 | 0.050 |
Why?
| | Echocardiography | 2 | 2021 | 642 | 0.050 |
Why?
| | Child, Preschool | 4 | 2021 | 11074 | 0.050 |
Why?
| | Models, Theoretical | 1 | 2007 | 578 | 0.050 |
Why?
| | Receptors, Adrenergic | 1 | 2023 | 33 | 0.050 |
Why?
| | Cardiovascular Agents | 1 | 2025 | 159 | 0.050 |
Why?
| | Phosphoproteins | 2 | 2019 | 338 | 0.050 |
Why?
| | Prenatal Diagnosis | 1 | 2024 | 201 | 0.050 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 2 | 2014 | 114 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2008 | 2031 | 0.050 |
Why?
| | Sarcomeres | 1 | 2023 | 96 | 0.050 |
Why?
| | Up-Regulation | 2 | 2018 | 843 | 0.050 |
Why?
| | Rats | 2 | 2021 | 5647 | 0.050 |
Why?
| | Epigastric Arteries | 1 | 2022 | 26 | 0.050 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2021 | 455 | 0.050 |
Why?
| | Lung | 3 | 2024 | 4060 | 0.050 |
Why?
| | Endopeptidase K | 1 | 2021 | 17 | 0.050 |
Why?
| | Ribonucleases | 1 | 2021 | 55 | 0.050 |
Why?
| | Light Coagulation | 1 | 2021 | 8 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2024 | 4295 | 0.050 |
Why?
| | Molecular Sequence Data | 3 | 2014 | 2900 | 0.050 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2021 | 38 | 0.050 |
Why?
| | Serum Response Factor | 1 | 2021 | 33 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2021 | 1396 | 0.040 |
Why?
| | Fetoscopy | 1 | 2021 | 30 | 0.040 |
Why?
| | Muscle, Skeletal | 1 | 2011 | 1724 | 0.040 |
Why?
| | Phenylthiohydantoin | 1 | 2021 | 42 | 0.040 |
Why?
| | Microscopy, Atomic Force | 1 | 2021 | 126 | 0.040 |
Why?
| | Bacteria | 1 | 2007 | 858 | 0.040 |
Why?
| | DNA Primers | 2 | 2012 | 515 | 0.040 |
Why?
| | Body Temperature | 2 | 2012 | 222 | 0.040 |
Why?
| | Cardiac Output, Low | 1 | 2021 | 66 | 0.040 |
Why?
| | Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2020 | 7 | 0.040 |
Why?
| | Adenosine Monophosphate | 1 | 2021 | 66 | 0.040 |
Why?
| | Blotting, Western | 2 | 2014 | 1226 | 0.040 |
Why?
| | Drainage | 1 | 2021 | 173 | 0.040 |
Why?
| | Cardiotonic Agents | 1 | 2021 | 124 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2020 | 50 | 0.040 |
Why?
| | Nitriles | 1 | 2021 | 172 | 0.040 |
Why?
| | Benzamides | 1 | 2021 | 216 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 1993 | 0.040 |
Why?
| | Adult | 5 | 2024 | 37929 | 0.040 |
Why?
| | Infant | 3 | 2020 | 9465 | 0.040 |
Why?
| | Hominidae | 2 | 2014 | 85 | 0.040 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2020 | 127 | 0.040 |
Why?
| | Androgens | 1 | 2021 | 187 | 0.040 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2020 | 132 | 0.040 |
Why?
| | Mass Spectrometry | 2 | 2014 | 739 | 0.040 |
Why?
| | Dopamine | 1 | 2022 | 303 | 0.040 |
Why?
| | Injections, Intralesional | 1 | 2019 | 34 | 0.040 |
Why?
| | Ultrasonography, Prenatal | 1 | 2021 | 285 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2012 | 1316 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2019 | 115 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 730 | 0.040 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2018 | 37 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 452 | 0.040 |
Why?
| | Fetal Growth Retardation | 1 | 2024 | 565 | 0.040 |
Why?
| | Cell Cycle | 1 | 2021 | 601 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1738 | 0.040 |
Why?
| | Cohort Studies | 2 | 2022 | 5742 | 0.030 |
Why?
| | Transcription Factors | 2 | 2019 | 1719 | 0.030 |
Why?
| | Freezing | 1 | 2018 | 90 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2018 | 399 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2025 | 10811 | 0.030 |
Why?
| | Placenta | 1 | 2024 | 750 | 0.030 |
Why?
| | Pilot Projects | 1 | 2022 | 1710 | 0.030 |
Why?
| | Arenaviridae Infections | 1 | 2016 | 8 | 0.030 |
Why?
| | Cell Degranulation | 1 | 2016 | 41 | 0.030 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 80 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 976 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 5757 | 0.030 |
Why?
| | Lectins, C-Type | 1 | 2016 | 67 | 0.030 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2016 | 29 | 0.030 |
Why?
| | Granzymes | 1 | 2016 | 50 | 0.030 |
Why?
| | Critical Illness | 1 | 2022 | 811 | 0.030 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2016 | 224 | 0.030 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2021 | 801 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 430 | 0.030 |
Why?
| | Middle Aged | 4 | 2025 | 33479 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 2074 | 0.030 |
Why?
| | Nucleic Acid Hybridization | 2 | 2007 | 190 | 0.030 |
Why?
| | Pan troglodytes | 2 | 2007 | 63 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1060 | 0.030 |
Why?
| | Cell Line | 1 | 2021 | 2847 | 0.030 |
Why?
| | Chemokines | 1 | 2016 | 228 | 0.030 |
Why?
| | Risk Factors | 2 | 2021 | 10388 | 0.030 |
Why?
| | Prognosis | 2 | 2015 | 4030 | 0.030 |
Why?
| | Hot Temperature | 1 | 2018 | 391 | 0.030 |
Why?
| | Genotype | 1 | 2020 | 1916 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2016 | 189 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 1079 | 0.030 |
Why?
| | Transcription Termination, Genetic | 1 | 2014 | 19 | 0.030 |
Why?
| | Retroelements | 1 | 2014 | 48 | 0.030 |
Why?
| | Adolescent | 3 | 2021 | 21513 | 0.030 |
Why?
| | Immunologic Memory | 1 | 2016 | 353 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2015 | 307 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2016 | 491 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2021 | 2475 | 0.030 |
Why?
| | Cadherins | 1 | 2015 | 206 | 0.030 |
Why?
| | Sirtuin 3 | 1 | 2014 | 61 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 510 | 0.030 |
Why?
| | Acetylation | 1 | 2014 | 248 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2828 | 0.030 |
Why?
| | ROC Curve | 1 | 2015 | 554 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2024 | 6079 | 0.030 |
Why?
| | CD146 Antigen | 1 | 2012 | 42 | 0.020 |
Why?
| | Myeloid Ecotropic Viral Integration Site 1 Protein | 1 | 2012 | 10 | 0.020 |
Why?
| | Bacterial Load | 1 | 2012 | 68 | 0.020 |
Why?
| | Bronchoalveolar Lavage | 1 | 2012 | 93 | 0.020 |
Why?
| | RNA, Neoplasm | 1 | 2012 | 82 | 0.020 |
Why?
| | Mycoplasma pneumoniae | 1 | 2012 | 57 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2022 | 15657 | 0.020 |
Why?
| | Peptide Library | 1 | 2012 | 92 | 0.020 |
Why?
| | Skinfold Thickness | 1 | 2012 | 46 | 0.020 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2012 | 57 | 0.020 |
Why?
| | alpha-Macroglobulins | 1 | 2012 | 24 | 0.020 |
Why?
| | Selection, Genetic | 1 | 2014 | 273 | 0.020 |
Why?
| | Body Fat Distribution | 1 | 2012 | 49 | 0.020 |
Why?
| | Cystathionine beta-Synthase | 1 | 2012 | 71 | 0.020 |
Why?
| | Receptors, Complement 3b | 1 | 2012 | 84 | 0.020 |
Why?
| | Toll-Like Receptor 2 | 1 | 2012 | 115 | 0.020 |
Why?
| | Adenoviridae | 1 | 2012 | 193 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2012 | 316 | 0.020 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2012 | 100 | 0.020 |
Why?
| | Citric Acid Cycle | 1 | 2011 | 57 | 0.020 |
Why?
| | Gene Transfer Techniques | 1 | 2012 | 170 | 0.020 |
Why?
| | Serum Albumin | 1 | 2012 | 150 | 0.020 |
Why?
| | Dogs | 1 | 2012 | 413 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2012 | 318 | 0.020 |
Why?
| | Thermogenesis | 1 | 2011 | 44 | 0.020 |
Why?
| | Hindlimb | 1 | 2011 | 128 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 686 | 0.020 |
Why?
| | Exons | 1 | 2012 | 355 | 0.020 |
Why?
| | Heat-Shock Proteins | 1 | 2011 | 143 | 0.020 |
Why?
| | Young Adult | 2 | 2021 | 13209 | 0.020 |
Why?
| | Glycine | 1 | 2011 | 176 | 0.020 |
Why?
| | DNA Barcoding, Taxonomic | 1 | 2010 | 22 | 0.020 |
Why?
| | Acetyltransferases | 1 | 2010 | 22 | 0.020 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2010 | 122 | 0.020 |
Why?
| | Gene Library | 1 | 2010 | 118 | 0.020 |
Why?
| | Arginine | 1 | 2011 | 271 | 0.020 |
Why?
| | NAD | 1 | 2010 | 77 | 0.020 |
Why?
| | Genetic Engineering | 1 | 2010 | 93 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2012 | 513 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2012 | 391 | 0.020 |
Why?
| | Genes | 1 | 2010 | 230 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 5131 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 2012 | 434 | 0.020 |
Why?
| | Gestational Age | 1 | 2012 | 910 | 0.020 |
Why?
| | NF-kappa B | 1 | 2012 | 691 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2016 | 1991 | 0.020 |
Why?
| | Gene Deletion | 1 | 2010 | 391 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 506 | 0.020 |
Why?
| | Lactic Acid | 1 | 2010 | 305 | 0.020 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2010 | 328 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2011 | 518 | 0.020 |
Why?
| | False Positive Reactions | 1 | 2008 | 115 | 0.020 |
Why?
| | Apoptosis | 1 | 2017 | 2553 | 0.020 |
Why?
| | Radiographic Image Enhancement | 1 | 2008 | 58 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2757 | 0.020 |
Why?
| | Neutrophils | 1 | 2012 | 1238 | 0.020 |
Why?
| | Genetic Diseases, Inborn | 1 | 2007 | 44 | 0.020 |
Why?
| | Base Sequence | 1 | 2010 | 2181 | 0.020 |
Why?
| | Mammography | 1 | 2008 | 154 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2010 | 1060 | 0.020 |
Why?
| | Gene Rearrangement | 1 | 2007 | 150 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2012 | 1431 | 0.020 |
Why?
| | Heat-Shock Response | 1 | 2006 | 77 | 0.010 |
Why?
| | Aged | 1 | 2025 | 23961 | 0.010 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 2004 | 15 | 0.010 |
Why?
| | Chromosomes, Artificial, Bacterial | 1 | 2004 | 19 | 0.010 |
Why?
| | Pongo pygmaeus | 1 | 2004 | 7 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 2006 | 337 | 0.010 |
Why?
| | Cytokines | 1 | 2012 | 2085 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2007 | 1062 | 0.010 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2004 | 113 | 0.010 |
Why?
| | Environment | 1 | 2006 | 358 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2004 | 272 | 0.010 |
Why?
| | Age Factors | 1 | 2011 | 3295 | 0.010 |
Why?
| | Quantitative Trait Loci | 1 | 2006 | 380 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2004 | 534 | 0.010 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2004 | 317 | 0.010 |
Why?
| | Biomedical Research | 1 | 2007 | 692 | 0.010 |
Why?
| | Biological Evolution | 1 | 2004 | 474 | 0.010 |
Why?
| | Sleep | 1 | 2006 | 755 | 0.010 |
Why?
| | Alcoholism | 1 | 2006 | 807 | 0.010 |
Why?
| | Proteins | 1 | 2004 | 1009 | 0.010 |
Why?
| | Time Factors | 1 | 2007 | 6828 | 0.010 |
Why?
|
|
Karimpour-Fard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|